Endocrinology · 1985 · 133 citations · 11 references
Life SciencesBiochemistryEndocrinologyHormone BiochemistryNeuroendocrinologySteroid BiochemistryAdrenal HormonesGrowth HormoneHormone ReleaseHypothalamic-pituitary RegulationPituitary Hormone RegulationPituitary HormonesAnterior Pituitary Hormone SecretionEquilibrium Dissociation ConstantGrowth Hormone ReceptorsHypothalamic-pituitary-growth AxisPituitary Somatotroph FunctionResponsiveness
Specific high affinity binding sites for growth hormone releasing factor (GRF) were described in rat anterior pituitary homogenates with use of the analog [His1-mono-125I-Tyr10,Nle27]-hGRF(1-32)-NH2 as radioligand. Computerized analysis of competition experiments indicated one class of specific high affinity binding sites with a dissociation constant of 0.19 nM. The relative binding affinities of rGRF, hGRF(1-40) and various analogs correlated well with their in vitro biological potencies. Further, the number binding sites was drastically decreased after adrenalectomy; chronic dexamethasone treatment of these animals restored GRF binding capacity to control without changing binding affinity. These results may in part explain the enhanced responsiveness of the somatotroph after dexamethasone treatment.
11
André DeLÉAN, Peter J. Munson, David Rodbard · American Journal of Physiology-Endocrinology and Metabolism · 1978 · 2.4K citations
Growth Hormone-Releasing Factor from a Human Pancreatic Tumor That Caused Acromegaly
Roger Guillemin, Paul Brazeau, Peter Böhlen et al. · Science · 1982 · 1.3K citations
Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour
Jean Rivier, Joachim Spiess, Michael O. Thorner et al. · Nature · 1982 · 1.1K citations
Medicine, Endocrinology, Oncology +14
Characterization of rat hypothalamic growth hormone-releasing factor
Joachim Spiess, Jean Rivier, Wylie Vale · Nature · 1983 · 371 citations